A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
University of Pittsburgh
University of Pittsburgh
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
CivaTech Oncology
University of Massachusetts, Worcester
Center for Biomedical Research, Inc.
Rhode Island Hospital
Johns Hopkins University
The Cleveland Clinic
University of Virginia
Massachusetts General Hospital